Does Rallies track congressional trades in IRTC?

Yes. Rallies tracks politician and congressional stock disclosures for IRTC, including reported purchases, sales, dates, owners, and trade amounts when available.

Is IRTC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IRTC. It does not provide personalized investment advice.

IRTC (iRhythm Holdings, Inc. Common Stock) Stock Analysis - Politician Trades

iRhythm Holdings, Inc. Common Stock (IRTC) is a publicly traded Healthcare sector company. As of May 21, 2026, IRTC trades at $117.02 with a market cap of $3.65B and a P/E ratio of -83.62. IRTC moved +2.80% today. Year to date, IRTC is -36.55%; over the trailing twelve months it is -17.14%. Its 52-week range spans $55.92 to $212.00. Analyst consensus is strong buy with an average price target of $184.00. Rallies surfaces IRTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded IRTC stock?

Recent politician trading activity in IRTC includes disclosures from Richard Blumenthal. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

IRTC Key Metrics

Key financial metrics for IRTC
Metric	Value
Price	$117.02
Market Cap	$3.65B
P/E Ratio	-83.62
EPS	$-1.39
Dividend Yield	0.00%
52-Week High	$212.00
52-Week Low	$55.92
Volume	1
Avg Volume	0
Revenue (TTM)	$747.14M
Net Income	$-44.55M
Gross Margin	70.57%

Congressional Trades in IRTC

Richard Blumenthal sale IRTC on Aug 14, 2025 (amount: $15.00K) for Spouse.

Latest IRTC News

iRhythm Q1 Revenue Jumps 25.7% to $199.4M; Full-Year Guidance Upgraded — Apr 30, 2026
iRhythm Data Shows 26% Post-Ablation AF Recurrences, 60% Pregnancy Arrhythmias Detected After 48 Hours — Apr 27, 2026
iRhythm launches Academy, shows 48% arrhythmia in CKD and 2.8x AF risk — Mar 30, 2026
iRhythm Appoints UnitedHealth Enterprise Strategy EVP Jason Patten to Board — Mar 12, 2026
iRhythm Reports Q4 Revenue Up 27.1% to $208.9M, First GAAP Profit — Mar 2, 2026

Recent IRTC Insider Trades

TALWALKAR ABHIJIT Y bought 5.31K (~$56.89K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 940 (~$109.09K) on May 11, 2026.
TALWALKAR ABHIJIT Y sold 642 (~$75.10K) on May 11, 2026.

IRTC Analyst Consensus

13 analysts cover IRTC: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $184.00.

Common questions about IRTC

Which politicians traded IRTC stock?: Recent politician trading activity in IRTC includes disclosures from Richard Blumenthal. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in IRTC?: Yes. Rallies tracks politician and congressional stock disclosures for IRTC, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IRTC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IRTC. It does not provide personalized investment advice.